We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$117M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$39.8M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$27.4M
4
APO icon
Apollo Global Management
APO
+$17.4M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$13.7M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$13.8M
2
TPL icon
Texas Pacific Land
TPL
+$5.86M
3
LII icon
Lennox International
LII
+$5.09M
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$4.62M
5
SWN
Southwestern Energy Company
SWN
+$4.05M

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFS icon
2701
GlobalFoundries
GFS
$29.2B
$74.1K ﹤0.01%
1,727
+5
+0.3% +$209
PRME icon
2702
Prime Medicine
PRME
$580M
$73.1K ﹤0.01%
25,031
-9,097
-27% -$31.9K
NWL icon
2703
Newell Brands
NWL
$2.62B
$72.6K ﹤0.01%
7,287
+20
+0.3% +$181
SRI icon
2704
Stoneridge
SRI
$197M
$71.8K ﹤0.01%
11,450
-4,414
-28% -$33.9K
CRD.A icon
2705
Crawford & Co Class A
CRD.A
$640M
$71.5K ﹤0.01%
6,185
-2,370
-28% -$27.2K
LRMR icon
2706
Larimar Therapeutics
LRMR
$454M
$71.3K ﹤0.01%
18,428
-6,377
-26% -$42.1K
TXG icon
2707
10x Genomics
TXG
$7.52B
$71.3K ﹤0.01%
4,963
-33
-0.7% -$521
CATX icon
2708
Perspective Therapeutics
CATX
$372M
$70.9K ﹤0.01%
22,228
-8,937
-29% -$73K
CRBP icon
2709
Corbus Pharmaceuticals
CRBP
$189M
$70.2K ﹤0.01%
5,951
– –
ZNTL icon
2710
Zentalis Pharmaceuticals
ZNTL
$307M
$69.6K ﹤0.01%
22,971
-11,119
-33% -$36.4K
OGN icon
2711
Organon & Co
OGN
$3.59B
$67.4K ﹤0.01%
4,519
+13
+0.3% +$212
FSP
2712
Franklin Street Properties
FSP
$46.3M
$67.2K ﹤0.01%
36,712
+19,873
+118% +$36.3K
INZY
2713
DELISTED
Inozyme Pharma
INZY
$66.4K ﹤0.01%
23,958
-3,991
-14% -$15.2K
DNB
2714
DELISTED
Dun & Bradstreet
DNB
$66.2K ﹤0.01%
5,313
+15
+0.3% +$179
BEPC icon
2715
Brookfield Renewable
BEPC
$6.5B
$65.6K ﹤0.01%
2,373
+6
+0.3% +$184
SMHI icon
2716
SEACOR Marine Holdings
SMHI
$264M
$64.8K ﹤0.01%
9,874
-4,244
-30% -$31.5K
FWONA icon
2717
Liberty Media Series A
FWONA
$23.7B
$64.7K ﹤0.01%
770
-11
-1% -$855
MDU icon
2718
MDU Resources
MDU
$4.32B
$64.3K ﹤0.01%
3,568
-186,616
-98% -$3.27M
LNAI
2719
Lunai Bioworks
LNAI
$10.7M
$63K ﹤0.01%
+943
New +$62.6K
DXC icon
2720
DXC Technology
DXC
$1.71B
$62.8K ﹤0.01%
3,142
+9
+0.3% +$190
ADCT icon
2721
ADC Therapeutics
ADCT
$156M
$61.9K ﹤0.01%
31,117
-11,972
-28% -$31.3K
HSHP
2722
Himalaya Shipping
HSHP
$703M
$61.7K ﹤0.01%
12,692
-5,423
-30% -$35.5K
TSVT
2723
DELISTED
2seventy bio
TSVT
$61.6K ﹤0.01%
20,967
-8,692
-29% -$35.7K
TNGX icon
2724
Tango Therapeutics
TNGX
$4.31B
$60.7K ﹤0.01%
19,631
-8,633
-31% -$40.1K
CHGG icon
2725
Chegg
CHGG
$88.9M
$59.5K ﹤0.01%
36,967
+19,153
+108% +$35.3K
107 108
109
110 111

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.